Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.
Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies. — المؤلف: Tay-Teo, Kiu — JAMA network open 20191120
- المؤلف
- Tay-Teo, Kiu
- النشر
- JAMA network open 20191120
- الوصف
- e186875 p.
- الموضوعات
- Antineoplastic Agents؛ Drug Approval؛ Drug Costs؛ Drug Industry؛ Global Health؛ Humans؛ Income؛ Marketing